We are live on !
Find out more
Lifeworks Advisors Portfolio holdings
AUM
$955M
Turnover
18.05%
1-Year Est. Return
37.71%
This Fund
S&P 500
This Quarter Est. Return
-11.47%
1 Year Est. Return
+37.71%
3 Year Est. Return
+80.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$158M
AUM Growth
+$6.31M
(+4.2%)
Cap. Flow
+$71.3M
Cap. Flow % of AUM
Cap. Flow %
45.18%
Top 10 Holdings %
Top 10 Hldgs %
28.32%
Holding
151
New
24
Increased
86
Reduced
24
Closed
9
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.7M |
| 2 |
Gilead Sciences
GILD
|
+$2.88M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$2.46M |
| 4 |
Seagate
STX
|
+$1.45M |
| 5 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$901K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$1.32M |
| 2 |
Trimble
TRMB
|
+$745K |
| 3 |
Eastman Chemical
EMN
|
+$714K |
| 4 |
eBay
EBAY
|
+$437K |
| 5 |
Alliant Energy
LNT
|
+$285K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.65% |
| 2 | Healthcare | 25.69% |
| 3 | Miscellaneous | 24.66% |
| 4 | Consumer Staples | 6.18% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
VanEck Merk Gold Trust
OUNZ
$2.6B
| $6.08M | 3.86% |
347,106
+21,684
| +7% | +$394K |
2021 Q4
2 quarters
|
|
|
2
Fidelity MSCI Health Care Index ETF
FHLC
$4.04B
| $6M | 3.81% |
98,950
+14,516
| +17% | +$901K |
2021 Q4
2 quarters
|
|
3
Fidelity MSCI Information Technology Index ETF
FTEC
$19.7B
| $5.96M | 3.78% |
61,714
+2,647
| +4% | +$282K |
2021 Q4
2 quarters
|
|
4
Johnson & Johnson
JNJ
$676B
| $4.6M | 2.92% |
25,918
+1,836
| +8% | +$327K |
2021 Q4
2 quarters
|
|
5
Microsoft
MSFT
$3.96T
| $4.5M | 2.85% |
17,502
+1,347
| +8% | +$366K |
2021 Q4
2 quarters
|
|
6
Apple
AAPL
$5.06T
| $3.9M | 2.48% |
28,555
-207
| -0.7% | -$31.3K |
2021 Q4
2 quarters
|
|
7
AbbVie
ABBV
$519B
| $3.7M | 2.34% |
24,139
+2,504
| +12% | +$383K |
2021 Q4
2 quarters
|
|
8
Merck
MRK
$365B
| $3.4M | 2.16% |
37,292
+608
| +2% | +$53.9K |
2021 Q4
2 quarters
|
|
9
Schwab Short-Term US Treasury ETF
SCHO
$15.6B
| $3.34M | 2.12% |
135,970
+380
| +0.3% | +$9.37K |
2021 Q4
2 quarters
|
|
10
Eli Lilly
LLY
$1.28T
| $3.19M | 2.02% |
9,850
-633
| -6% | -$190K |
2021 Q4
2 quarters
|
|
|
11
Gilead Sciences
GILD
$212B
| $3.19M | 2.02% |
51,543
+46,437
| +909% | +$2.88M |
2022 Q1
1 quarter
|
|
12
Pfizer
PFE
$167B
| $3.18M | 2.02% |
60,703
+5,454
| +10% | +$278K |
2021 Q4
2 quarters
|
|
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$796B
| $3.11M | 1.97% |
113,474
+109,171
| +2,537% | +$44.7M |
2021 Q4
2 quarters
|
|
14
Oracle
ORCL
$368B
| $2.86M | 1.81% |
40,863
+6,995
| +21% | +$512K |
2021 Q4
2 quarters
|
|
15
Cisco
CSCO
$387B
| $2.83M | 1.8% |
66,430
+13,952
| +27% | +$668K |
2021 Q4
2 quarters
|
|
16
Amgen
AMGN
$252B
| $2.8M | 1.77% |
11,506
+846
| +8% | +$207K |
2021 Q4
2 quarters
|
|
17
Biogen
BIIB
$37.4B
| $2.75M | 1.74% |
13,491
+1,256
| +10% | +$257K |
2021 Q4
2 quarters
|
|
18
Intercontinental Exchange
ICE
$98.6B
| $2.56M | 1.63% |
27,269
+7,440
| +38% | +$795K |
2021 Q4
2 quarters
|
|
19
Motorola Solutions
MSI
$87.2B
| $2.42M | 1.53% |
11,534
+2,039
| +21% | +$445K |
2021 Q4
2 quarters
|
|
|
20
Regeneron Pharmaceuticals
REGN
$94.8B
| $2.24M | 1.42% |
+3,787
| New | +$2.46M |
2022 Q2
0 quarters
|
|
21
Abbott
ABT
$191B
| $2.23M | 1.41% |
20,519
+4,507
| +28% | +$512K |
2021 Q4
2 quarters
|
|
22
Bio-Rad Laboratories Class A
BIO
$10.4B
| $2.07M | 1.31% |
4,173
-295
| -7% | -$154K |
2021 Q4
2 quarters
|
|
23
Qualcomm
QCOM
$186B
| $2.01M | 1.27% |
15,721
+3,346
| +27% | +$454K |
2021 Q4
2 quarters
|
|
24
IBM
IBM
$231B
| $1.96M | 1.24% |
13,854
+3,615
| +35% | +$488K |
2021 Q4
2 quarters
|
|
25
Intel
INTC
$309B
| $1.92M | 1.22% |
51,350
+9,199
| +22% | +$398K |
2021 Q4
2 quarters
|
|
Similar funds
Lifeworks Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Lifeworks Advisors held 151 positions worth $158M, up 4.2% from $151M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Lifeworks Advisors deployed $71.3M of net new capital in Q2 2022, opening 24 new positions and adding to 86 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 3,787 shares worth $2.24M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was eBay, an estimated $437K trimmed.
- Lifeworks Advisors's largest Q2 2022 buy was Regeneron Pharmaceuticals: 3,787 shares worth $2.24M.
- Lifeworks Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $44.7M increase.
- Lifeworks Advisors's biggest Q2 2022 reduction was eBay, cutting an estimated $437K.
- Lifeworks Advisors fully exited Zebra Technologies in Q2 2022, selling an estimated $1.32M.
- Lifeworks Advisors's ten largest holdings make up 28% of its $158M portfolio in Q2 2022.
- Lifeworks Advisors opened 24 new positions and closed 9 in Q2 2022.
- Lifeworks Advisors's portfolio value rose 4.2% quarter-over-quarter to $158M.
Based on Lifeworks Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.